GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38941
Submission : 2023-10-09
Status : Active
Type : IV

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38941
Submission : 2023-10-09
Status : Active
Type : IV

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FINISHED DOSAGE FORMULATIONS
Drug : BETAGAN
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Application Number : 19814
Country : US
Patented : No
Drug : BETAGAN
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Application Number : 19219
Country : US
Patented : No
PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM
Drug : BLEPHAMIDE
Dosage Form : SUSPENSION; OPHTHALMIC
Application Number : 12813
Country : US
Patented : No
Drug : ASCLERA
Dosage Form : SOLUTION; INTRAVENOUS
Application Number : 21201
Country : US
Patented : No
Drug : DECITABINE
Dosage Form : INJECTABLE; INTRAVENOUS
Application Number : 203131
Country : US
Patented : No
Drug : PREDNISOLONE SODIUM PHOSPHATE
Dosage Form : SOLUTION; ORAL
Application Number : 91396
Country : US
Patented : No
Drug : DECITABINE
Dosage Form : INJECTABLE; INTRAVENOUS
Application Number : 203475
Country : US
Patented : No

Drug : RANITIDINE HYDROCHLORIDE
Dosage Form : SYRUP; ORAL
Application Number : 76124
Country : US
Patented : No

Drug : VITRASE
Dosage Form : INJECTABLE; INJECTION
Application Number : 21640
Country : US
Patented : No

Drug : DECITABINE
Dosage Form : INJECTABLE; INTRAVENOUS
Application Number : 206033
Country : US
Patented : No

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EXCIPIENTS BY APPLICATIONS